Literature DB >> 18507494

Increasing rates of placebo response over time in mania studies.

Eduard Vieta, Nuria Cruz.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18507494     DOI： 10.4088/jcp.v69n0423g

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  5 in total

Review 1.  Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.

Authors:  Ayşegül Yildiz; Eduard Vieta; Stefan Leucht; Ross J Baldessarini
Journal:  Neuropsychopharmacology       Date:  2010-10-27       Impact factor: 7.853

Review 2.  Using Artificial Intelligence-based Methods to Address the Placebo Response in Clinical Trials.

Authors:  Erica A Smith; William P Horan; Dominique Demolle; Peter Schueler; Dong-Jing Fu; Ariana E Anderson; Joseph Geraci; Florence Butlen-Ducuing; Jasmine Link; Ni A Khin; Robert Morlock; Larry D Alphs
Journal:  Innov Clin Neurosci       Date:  2022 Jan-Mar

3.  Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis.

Authors:  Konstantinos N Fountoulakis; Xenia Gonda; Eduard Vieta; Frank Schmidt
Journal:  Ann Gen Psychiatry       Date:  2009-12-31       Impact factor: 3.455

Review 4.  Placebo Effect in Obsessive-Compulsive Disorder (OCD). Placebo Response and Placebo Responders in OCD: The Trend Over Time.

Authors:  Georgios D Kotzalidis; Antonio Del Casale; Maurizio Simmaco; Lucia Pancheri; Roberto Brugnoli; Marco Paolini; Ida Gualtieri; Stefano Ferracuti; Valeria Savoja; Ilaria Cuomo; Lavinia De Chiara; Alessio Mosca; Gabriele Sani; Paolo Girardi; Maurizio Pompili; Chiara Rapinesi
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

5.  Placebo Response and Its Predictors in Attention Deficit Hyperactivity Disorder: A Meta-Analysis and Comparison of Meta-Regression and MetaForest.

Authors:  Xavier Castells; Marc Saez; Maghie Barcheni; Ruth Cunill; Domènec Serrano; Beatriz López; Caspar J van Lissa
Journal:  Int J Neuropsychopharmacol       Date:  2022-01-12       Impact factor: 5.176
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.